학술논문
Tislelizumab Plus Chemotherapy as First-Line Treatment for Locally Advanced or Metastatic Nonsquamous NSCLC (RATIONALE 304): A Randomized Phase 3 Trial
Document Type
Article
Author
Source
In Journal of Thoracic Oncology September 2021 16(9):1512-1522
Subject
Language
ISSN
1556-0864